抗体

载脂蛋白e重组兔单克隆抗体[SC0536](ET1610-22)

ET1610-22

单克隆

SC0536

单克隆

domestic rabbit

未共轭

SC0536

免疫印迹, 免疫细胞化学, 免疫沉淀, 免疫组化-石蜡切片

载脂蛋白e重组兔单克隆抗体[SC0536](ET1610-22)

Recombinant Rabbit monoclonal primary

未共轭

单克隆

SC0536

兔

免疫印迹, 免疫细胞化学, IF, 免疫组化-P, 免疫沉淀

WB: 1:1, 000-1:5, 000;免疫细胞化学/IF:1:50-1:200;免疫组化-P:1:50-1:200

人类

Synthetic peptide within C-terminal human Apolipoprotein E.

IgG

载脂蛋白e

P02649

AD2抗体;载脂蛋白E抗体;APOE抗体;APOE_HUMAN抗体;APOEA抗体;载脂蛋白e抗体;载脂蛋白E3抗体;载脂蛋白抗体;载脂蛋白抗体;LDLCQ5抗体;LPG抗体

Apolipoprotein-E (apoE) is a protein component of plasma lipoproteins that mediates the binding, internalization and catabolism of lipoprotein particles. It can serve as a ligand for several lipoprotein receptors, including the LDL (ApoB/E) receptor and the hepatic apoE (chylomicron remnant) receptor. apoE is produced in most organs and occurs in all plasma lipoprotein fractions, constituting 10-20% of VLDL (very low density lipoprotein) and 1-2% of HDL (high density lipoprotein). Three major isoforms of apoE have been described in human (E2, E3 and E4) which differ by only one or two amino acids. Estrogen receptor has been shown to upregulate apoE gene expression via the ERa-mediated pathway, indicating a potential role for apoE in atherosclerosis. This is consistent with studies in mice in which plasma apoE levels were raised, thereby protecting the mice from diet-induced atherosclerosis. apoE has also been shown to be a potent inhibitor of proliferation and thus may play a role in angiogenesis, tumor cell growth and metastasis.

液体

蛋白质A亲和纯化

1微克/微升

1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.

36 kDa

HUABIO

100ul

355

2020&prior